We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...

We recently published a list of Billionaire Steve Cohen’s Top 15 Stock Picks. In this article, we are going to take a look at ...

In recent years, the investment landscape has seen a significant shift towards socially responsible investing strategies.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Biotech giant Gilead Sciences, Inc. GILD has put up a strong performance amid a volatile market. Shares of this biotech giant ...

The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of 11.1%, reaching US$145.53 billion in 2024 and an impressive US$246.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Total product sales reached ... 59 hedge funds were bullish on Gilead Sciences, Inc. (NASDAQ:GILD), compared to 62 in the last quarter. Overall GILD ranks 13th on our list of the best pharma ...

Tecartus will launch with a $373,000 list price, around the same as Gilead/Kite's first CAR-T ... Novartis' rival Kymriah (tisagenlecleucel) product, which has also underwhelmed since launch ...

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...